Delivery Order SPE2DB22D9353-SPE2DB25FX2BL
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of 4,568,739,949 units of the drug daunorubicin 20 mg/4 ml vial, with a total ceiling value of $1,188.88. The contract has an ultimate completion date of July 1, 2025. DMS Pharmaceutical Group Inc. is an established pharmaceutical wholesaler that specializes in providing a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $55,310.55 on August 18, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which must be completed by August 20, 2025, does not utilize a set-aside designation. The award is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,862.94 on July 21, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, with an ultimate completion date of July 28, 2025, carries no set-aside designation and represents a continuation of the company's substantial role as a pharmaceutical supplier to the Department of Defense. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, received a firm fixed-price delivery order valued at $6,028.88 from the Defense Logistics Agency's Medical Supply Chain division on August 25, 2025. This delivery order, which will be completed by August 26, 2025, represents a task order issued under the company's larger Indefinite Delivery Contract with the DLA valued at $499.999 billion and valid through November 2026....
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order valued at $9,889.86 from the Defense Logistics Agency's Medical Supply Chain division on August 7, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 11, 2025, represents a task order issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $18,488.12 on August 12, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which is scheduled for completion by August 13, 2025, represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499.999 billion through November...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,449.60 award is for the delivery of 4563373091 - Doxorubicin 50 mg/25 ml Vial 25 ml, a chemotherapy medication. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 and running...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,339.18 by the Defense Logistics Agency's Medical Supply Chain division on August 4, 2025. This delivery order, which carries no set-aside designation, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency's Medical Supply Chain division on August 20, 2025. This delivery order, with an ultimate completion date of August 21, 2025, represents a single task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of pharmaceutical products including medications and medical supplies. The delivery order, valued at $2,494.50, has a completion date of September 13, 2022. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group worth up to $499,999,999, which allows the DLA to issue...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB25FX2BLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,783.32 to DMS Pharmaceutical Group Inc. for Daunorubicin 20 mg/4 ml vials on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a pharmaceutical supply requirement for an oncology medication used in cancer treatment protocols. The award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly based on its capabilities as a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. Under this SPE2DB program vehicle, the agency can issue multiple firm fixed-price delivery orders for comprehensive pharmaceutical products supporting military health facilities worldwide. DMS Pharmaceutical Group serves as a critical supplier in the federal pharmaceutical supply chain, providing branded and generic prescription drugs, biologics, and medical consumables directly to Department of Defense healthcare sites, and has maintained a robust portfolio of delivery orders across diverse pharmaceutical categories since its SAM.gov registration in 2001.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/8/25 |